A female has hypopigmented lesion on centre of fore-head. Drug responsible is?
## **Core Concept**
The question pertains to a condition known as **monobenzone-induced vitiligo** or more generally, **chemical leukoderma**. This condition results from exposure to certain chemicals that destroy melanocytes, leading to depigmentation of the skin.
## **Why the Correct Answer is Right**
Monobenzone (also known as **monobenzyl ether of hydroquinone**) is a potent **skin depigmenting agent**. It works by inhibiting the enzyme **tyrosinase**, which is crucial for melanin production in melanocytes. Prolonged exposure to monobenzone can lead to the destruction of melanocytes, resulting in **hypopigmentation** or **vitiligo-like lesions**. The fact that the lesion is described as hypopigmented and located on the center of the forehead aligns with the potential for chemical exposure leading to such a condition.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific chemical name, it's hard to assess its accuracy directly, but generally, not all chemicals cause skin depigmentation.
- **Option B:** Similarly, without specifics, it's difficult to evaluate, but **para-phenylenediamine (PPD)** is more commonly associated with allergic contact dermatitis rather than depigmentation.
- **Option C:** This option is not provided, so we proceed with the understanding that **Option D** is the correct answer based on the information given.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **monobenzone** and other **hydroquinone derivatives** can cause **permanent depigmentation** if not handled properly. Individuals working with these chemicals should take precautions to avoid skin exposure.
## **Correct Answer:** D. Monobenzone.